Results 31 to 40 of about 3,722,377 (405)

Endoglin Expression (CD105) in Ephithelial Ovarian Cancer

Indonesian Journal of Obstetrics and Gynecology, 2018
Objective: Endoglin ( CD105 ) is one of the factors that play a role in vascular development , angiogenesis and vascular homeostasis. The aim of this research is to address the endoglin expression (CD105) in primary tumor and metastasis tumor (omentum ...
Rizkinov Jumsa, John Rambulangi, Sharvianty Arifuddin, Upik Miskad   +3 more
doaj   +1 more source

Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model

Advances in Therapy, 2019
Cowpea mosaic virus (CPMV) is a promising platform nanotechnology with applications as a cancer therapeutic. To understand the therapeutic potential of CPMV in more detail, its antitumor mechanisms are investigated using a syngeneic immunocompetent ...
Chao Wang, S. Fiering, N. Steinmetz
semanticscholar   +1 more source

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer

Cells, 2020
Tumor-associated macrophages (TAMs) constitute the main population of immune cells present in the ovarian tumor microenvironment. These cells are characterized by high plasticity and can be easily polarized by colony-stimulating factor-1, which is ...
M. Nowak, M. Klink
semanticscholar   +1 more source

Metastatic ovarian tumor

Journal of Cytology, 2009
58-year-old woman with a history of breast carcinoma presented with a bilateral ovarian tumor. On fine needle aspiration cytology, diagnosis of metastatic adenocarcinoma was made. At subsequent hysterectomy and bilateral salpingo-oophrectomy, specimen showed extensive metastatic carcinoma involving both ovaries.
Asotra Sarita, Sharma Jaishree, Sharma Neelam   +2 more
openaire   +3 more sources

Sialic Acid–Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments

Journal of Immunology, 2018
The tumor microenvironment is rendered immunosuppressive by a variety of cellular and acellular factors that represent potential cancer therapeutic targets.
Gautam N. Shenoy, Jenni L Loyall, C. Berenson, R. J. Kelleher, V. Iyer, S. Balu-Iyer, K. Odunsi, R. Bankert   +7 more
semanticscholar   +1 more source

Phenotypic and Functional Delineation of Murine CX3CR1+ Monocyte-Derived Cells in Ovarian Cancer

Neoplasia: An International Journal for Oncology Research, 2009
Ovarian tumor progression is marked by the peritoneal accumulation of leukocytes. Among these leukocytes, an immunosuppressive CD11b+CD11c+ population has been identified in both human and ovarian tumors.
Kevin M. Hart, S. Peter Bak, Anselmo Alonso, Brent Berwin   +3 more
doaj   +1 more source

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology: Clinical Research, 2018
We aimed to validate the prognostic association of p16 expression in ovarian high‐grade serous carcinomas (HGSC) and to explore it in other ovarian carcinoma histotypes.
P. Rambau, R. Vierkant, M. Intermaggio, L. Kelemen, M. Goodman, E. Herpel, P. Pharoah, S. Kommoss, M. Jimenez-Linan, B. Karlan, A. Gentry-Maharaj, U. Menon, Susanna Hernando Polo, F. J. Candido dos Reis, J. Doherty, S. Gayther, Raghwa N. Sharma, M. Larson, P. Harnett, E. Hatfield, J. M. de Andrade, G. Nelson, H. Steed, J. Schildkraut, M. E. Carney, E. Høgdall, A. Whittemore, M. Widschwendter, C. Kennedy, Frances F Wang, Qin Wang, Chen Wang, Sebastian M. Armasu, F. Daley, P. Coulson, Micheal E. Jones, M. Anglesio, C. Chow, A. De Fazio, M. García-Closas, S. Brucker, C. Cybulski, H. Harris, A. Hartkopf, T. Huzarski, A. Jensen, J. Lubiński, O. Oszurek, J. Benítez, Fady Mina, A. Staebler, F. Taran, J. Pasternak, A. Talhouk, M. Rossing, J. Hendley, R. Edwards, S. Fereday, F. Modugno, R. Ness, W. Sieh, M. El-Bahrawy, S. Winham, J. Lester, S. K. Kjaer, J. Gronwald, P. Sinn, P. Fasching, J. Chang-Claude, K. Moysich, D. Bowtell, B. Hernandez, H. Luk, S. Behrens, M. Shah, A. Jung, P. Ghatage, J. Alsop, K. Alsop, J. García-Donas, P. Thompson, A. Swerdlow, C. Karpinskyj, Alicia Cazorla-Jiménez, M. García, S. Deen, L. Wilkens, J. Palacios, A. Berchuck, J. Koziak, J. Brenton, L. Cook, E. Goode, D. Huntsman, S. Ramus, M. Köbel   +95 more
semanticscholar   +1 more source

Apoptotic and chemotherapeutic properties of iron(III)-salophene in an ovarian cancer animal model [PDF]

, 2008
The cytotoxicity of organometallic compounds iron(III)-, cobalt(III)-, manganese(II)-, and copper(II)-salophene (-SP) on platinum-resistant ovarian cancer cell lines was compared. Fe-SP displayed selective cytotoxicity (IC 50 at ∼1 μM) against SKOV-3 and
Alptürk, O, Brard, L, Kyu, KK, Lange, TS, Luisi, BS, McCourt, C, Singh, AP, Singh, RK, Strongin, RM   +8 more
core   +3 more sources

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer

Journal of Ovarian Research, 2018
BackgroundOvarian cancer is the major cause of death among gynecologic cancers with 75% of patients diagnosed with advanced disease, and only 20% of these patients having a survival duration of five years. Treatments blocking immune checkpoint molecules,
Loyola Ecommons, M. Drakes, S. Mehrotra, M. Aldulescu, R. Potkul, Yueying Liu, Anna Grisoli, Cara Joyce, T. O'Brien, T. O'brien, M. Stack   +10 more
semanticscholar   +1 more source

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers

Frontiers in Oncology, 2020
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to 50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate from resident tissue-specific macrophages and from newly recruited monocytes.
I. Larionova, G. Tuguzbaeva, A. Ponomaryova, M. Stakheyeva, N. Cherdyntseva, V. Pavlov, E. Choinzonov, J. Kzhyshkowska   +7 more
semanticscholar   +1 more source